Skip to main content
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.262
-0.023 (-8.04%)
At close: Apr 28, 2026, 4:00 PM EDT
0.264
+0.002 (0.76%)
Pre-market: Apr 29, 2026, 8:07 AM EDT

Outlook Therapeutics Revenue

Outlook Therapeutics had revenue of $-1.21M in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to $205.70K. In the fiscal year ending September 30, 2025, Outlook Therapeutics had annual revenue of $1.41M.

Revenue (ttm)
$205.70K
Revenue Growth
n/a
P/S Ratio
133.30
Revenue / Employee
$12,100
Employees
17
Market Cap
27.42M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20251.41M--
Sep 30, 2024---
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Celularity 40.58M
Neuphoria Therapeutics 14.99M
Apollomics 8.99M
Kyntra Bio 6.44M
Dyadic International 3.09M
Lisata Therapeutics 170.00K
Senti Biosciences Holdings 22.00K
Revenue Rankings

OTLK News

More News